Bioxytran Inc (BIXT)
0.102
0.00 (0.00%)
USD |
OTCM |
May 06, 15:56
Bioxytran Free Cash Flow (Quarterly): -0.0816M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.0816M |
December 31, 2023 | -0.0992M |
September 30, 2023 | -0.3553M |
June 30, 2023 | -0.1736M |
March 31, 2023 | -0.1916M |
December 31, 2022 | -0.1588M |
September 30, 2022 | -0.7265M |
June 30, 2022 | -0.2389M |
March 31, 2022 | -0.7137M |
December 31, 2021 | -0.1716M |
September 30, 2021 | -0.144M |
June 30, 2021 | -1.019M |
March 31, 2021 | -0.4001M |
December 31, 2020 | -0.8908M |
September 30, 2020 | -0.0117M |
June 30, 2020 | -0.0396M |
March 31, 2020 | -0.1568M |
December 31, 2019 | -0.1856M |
September 30, 2019 | -0.0321M |
June 30, 2019 | -0.0737M |
March 31, 2019 | -0.1397M |
December 31, 2018 | -0.1886M |
September 30, 2018 | 0.0028M |
June 30, 2018 | 0.00 |
March 31, 2018 | -0.0001M |
Date | Value |
---|---|
December 31, 2017 | -0.0309M |
September 30, 2017 | 0.0238M |
June 30, 2017 | -0.0034M |
March 31, 2017 | -0.008M |
December 31, 2016 | -0.0077M |
September 30, 2016 | -0.0039M |
June 30, 2016 | -0.0117M |
March 31, 2016 | -0.019M |
December 31, 2015 | -0.0132M |
September 30, 2015 | 0.0215M |
June 30, 2015 | -0.0076M |
March 31, 2015 | -0.0034M |
December 31, 2014 | -0.0173M |
September 30, 2014 | 0.0085M |
June 30, 2014 | -0.0465M |
March 31, 2014 | 0.0389M |
December 31, 2013 | 0.0043M |
September 30, 2013 | 0.0055M |
June 30, 2013 | -0.0939M |
March 31, 2013 | 0.0061M |
December 31, 2012 | -0.0055M |
September 30, 2012 | -0.0347M |
June 30, 2012 | -0.0113M |
March 31, 2012 | -0.0143M |
December 31, 2011 | -0.1927M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.019M
Minimum
Jun 2021
-0.0117M
Maximum
Sep 2020
-0.2932M
Average
-0.1726M
Median
Free Cash Flow (Quarterly) Benchmarks
Shuttle Pharmaceuticals Holdings Inc | -1.062M |
NovaBay Pharmaceuticals Inc | -0.316M |
Palatin Technologies Inc | -10.51M |
iBio Inc | -4.706M |
Theriva Biologics Inc | -6.597M |